LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Amgen Inc. on Thursday said it would pay GlaxoSmithKline more than $275 million to get out of a co-marketing agreement with the British drug company to promote Amgen’s osteoporosis drug Prolia in certain regions outside the United States.
Shares of Response Genetics Inc. jumped 18 percent on Thursday after the cancer diagnostic test company signed agreements with six additional health plans and two large health care groups.
MannKind Corp.'s share price more than doubled in after-hours trading Tuesday, following news that an FDA advisory panel had finally recommended approval of the Valencia company's Afrezza insulin inhaler.
Apollo Medical Holdings Inc. on Monday said it secured up to $12 million in capital from Fresenius Medical Care North America, a chain of dialysis clinics in Waltham, Mass.
TREATMENT: Keck sees patient volume soar after move closer to L.A. Live.
Hotels and nightlife venues aren’t the only establishments finding success by being near L.A. Live.
Shares of MannKind Corp. fell 7 percent on Friday after the FDA staff raised safety questions about the company’s inhalable insulin device, which could limit its use for certain patients.
Herbalife shares rose Monday after the company announced it is nominating three more designees of Carl Icahn to its board.
INVESTMENT: DPL taps South Korean money to back Israeli startups.
Trio gives birth to $50 million fund that will nurse Israeli life sciences startups with South Korean money.
Bill Gunderson shares the story of how Democratic operatives were enlisted to short Herbalife stock.
LAW: Plaintiff attorneys raise costs by going straight to filing.
Reform intended to curb abuse of the Americans With Disabilities Act has not stopped business owners from being sued multiple times for the same infraction.
Apollo Medical Holdings Inc. announced on Tuesday that it is partnering with Rite Aid Corp. to help manage the health of patients with chronic conditions.
Shares of Staar Surgical Co. jumped 15 percent on Monday after the lens company announced that a Food and Drug Administration advisory panel had recommended U.S. marketing approval for an implantable eye lens.
UCLA spinoff C3 Jian, Inc., which is developing drugs to fight tooth decay, on Monday said it raised $60.5 million in a just-completed Series D financing.
Shares of West L.A. biotechnology firm CytRx Corp. rebounded after falling as much as 10 percent Friday due to reports that the company has worked closely with a stock promoter to boost interest in its shares without disclosing its involvement.
Herbalife Ltd. on Thursday said that it would postpone next month's annual shareholder meeting for five days so it can continue discussions with Carl Icahn about adding more of his nominees to the company's board.